Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases

F Yang, J Xue, G Wang, Q Diao - Frontiers in pharmacology, 2022 - frontiersin.org
Cardiovascular disease is the most common health problem worldwide and remains the
leading cause of morbidity and mortality. Despite recent advances in the management of …

[HTML][HTML] Mesenchymal stem cell (MSCs) therapy for ischemic heart disease: a promising frontier

MS Poomani, I Mariappan, R Perumal, R Regurajan… - Global Heart, 2022 - ncbi.nlm.nih.gov
Although tremendous progress has been made in conventional treatment for ischemic heart
disease, it still remains a major cause of death and disability. Cell-based therapeutics holds …

Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction

Z Li, EG Solomonidis, M Meloni, RS Taylor… - European heart …, 2019 - academic.oup.com
Aims A better understanding of the pathways that regulate regeneration of the coronary
vasculature is of fundamental importance for the advancement of strategies to treat patients …

Effectiveness of exosome mediated miR-126 and miR-146a delivery on cardiac tissue regeneration

S Shafei, M Khanmohammadi, H Ghanbari… - Cell and Tissue …, 2022 - Springer
Despite advances in the treatment of acute myocardial infarction, due to the non-proliferative
nature of adult cardiomyocytes, the injured myocardium is mainly replaced by fibrotic tissue …

Nanoparticle-mediated drug delivery for treatment of ischemic heart disease

C Fan, J Joshi, F Li, B Xu, M Khan, J Yang… - … in bioengineering and …, 2020 - frontiersin.org
The regenerative capacity of an adult cardiac tissue is insufficient to repair the massive loss
of heart tissue, particularly cardiomyocytes (CMs), following ischemia or other catastrophic …

Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction

Z Wang, DW Long, Y Huang, WCW Chen, K Kim… - Acta biomaterialia, 2019 - Elsevier
Heart disease remains a leading killer in western society and irreversibly impacts the lives of
millions of patients annually. While adult mammals do not possess the ability to regenerate …

MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair

J Wang, CJ Lee, MB Deci, N Jasiewicz, A Verma… - … , Biology and Medicine, 2020 - Elsevier
Myocardial infarction (MI) remains a major cause of mortality worldwide. Despite significant
advances in MI treatment, many who survive the acute event are at high risk of chronic …

Thymoquinone protects against cardiac mitochondrial DNA loss, oxidative stress, inflammation and apoptosis in isoproterenol-induced myocardial infarction in rats

AA Khalifa, RM Rashad, WF El-Hadidy - Heliyon, 2021 - cell.com
Introduction Myocardial infarction (MI) is an ischemic life-threatening disease with
exaggerated oxidative stress state that vigorously damages the cardiomyocyte membrane …

[HTML][HTML] Potential therapeutic roles of stem cells in ischemia-reperfusion injury

M Barzegar, G Kaur, FNE Gavins, Y Wang, CJ Boyer… - Stem cell …, 2019 - Elsevier
Ischemia-reperfusion injury (I/RI), produced by an initial interruption of organ blood flow and
its subsequent restoration, contributes significantly to the pathophysiologies of stroke …

Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases

T Li, W Liang, X Xiao, Y Qian - International journal of …, 2018 - Taylor & Francis
Cardiovascular diseases (CVDs) are one of the most important causes of mortality and
affecting the health status of patients. At the same time, CVDs cause a huge health and …